Black Diamond Therapeutic...
2.15
-0.10 (-4.44%)
At close: Jan 15, 2025, 2:37 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -82.44M -91.17M -125.60M -67.25M -35.26M -8.93M -4.60M
Depreciation & Amortization 437.00K 508.00K 205.00K 52.00K 47.00K 44.00K 24.00K
Stock-Based Compensation 9.60M 12.20M 14.04M 7.76M 3.64M 64.00K 5.00K
Other Working Capital 3.09M -7.67M 5.45M 3.97M -991.00K 90.00K 1.80M
Other Non-Cash Items 2.00M 3.28M 2.01M 524.00K 6.43M 15.00K 66.00K
Deferred Income Tax n/a n/a 2.18M 1.73M n/a n/a 412.00K
Change in Working Capital 3.69M -9.90M 7.02M 5.04M 463.00K 354.00K 1.74M
Operating Cash Flow -66.72M -85.08M -100.15M -52.15M -24.67M -8.45M -2.35M
Capital Expenditures -33.00K -192.00K -2.71M -142.00K -21.00K -76.00K -77.00K
Acquisitions n/a 9.00K 2.70M 118.00K n/a n/a n/a
Purchase of Investments -61.89M -60.14M -49.51M -372.48M n/a n/a n/a
Sales Maturities Of Investments 78.17M 113.69M 182.83M 90.93M n/a n/a n/a
Other Investing Acitivies 95.00K 53.56K -2.70M -118.00K -21.00K n/a n/a
Investing Cash Flow 16.35M 53.37M 130.61M -281.69M -21.00K -76.00K -77.00K
Debt Repayment n/a n/a n/a n/a n/a n/a -50.00K
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 164.00K 177.00K 729.00K 1.10M 127.76M 52.31M 19.95M
Financial Cash Flow 71.93M 177.00K 729.00K 214.94M 127.76M 52.31M 9.97M
Net Cash Flow 21.56M -31.54M 31.19M -118.89M 103.06M 43.78M 7.55M
Free Cash Flow -66.75M -85.27M -102.86M -52.29M -24.70M -8.53M -2.43M